Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...

The FDA issued two policies April 12 to establish approaches for the design and validation of next-generation sequencing tests. Next-generation sequencing tests review a person’s DNA to diagnose ...

Next-generation DNA sequencing (NGS) has transformed the way scientists understand genetics. With the ability to sequence DNA and RNA faster and cheaper than ever before, this technology is reshaping ...

Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years.

Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...

The new resources will accelerate research and discovery across multiple health disciplines. UNT Health Fort Worth has launched a new High Performance Comput ...

Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp ...

This workshop explored the current use of DNA sequencing in newborns as well as the potential benefits and harms, associated ethical and data security issues, and equity in access to screening. A ...